ft 09 sep 93 uk compani news scotia look pound 30m list scotia hold pharm aceut compani built sale even primros oil float london stock market next month expect capitalis pound 160m scotia board yesterday approv final arrang flotat co ordin kleinwort benson accord pathfind prospectu issu today compani aim rais pound 30m base share price 260p 290p dr david horrobin chief execut said proce would use fund final develop six drug undergo clinic trial includ treatment cancer arthriti heart diseas complic diabet dr horrobin whose background academ medicin follow clear strategi ever sinc found compani known efamol 1979 quickli establish revenu stream sell nutrit supplement made seed oil even primros plant sale promot clinic studi show oil health benefit wide rang problem alcohol arthriti incom financ research develop prescript drug base mainli essenti fatti acid benefici chemic even primros oil scotia first drug epogam receiv uk licens 1988 treat skin disord eczema compani sinc receiv approv efamast breast pain efalith seborrho dermat anoth skin diseas compani distribut agreement intern pharmaceut group notabl searl subsidiari monsanto uk total sale scotia pharmaceut product year june 30 1993 exceed pound 20m compani receiv pound 7 4m counter sale worth pound 6 5m scotia made pre tax profit pound 1 1m 1991 92 mainli result front distribut payment searl follow year pre tax deficit pound 4 4m dr horrobin expect loss pound 6m pound 8m year next two three year period heavi r amp spend three advanc project ef4 treat nerv damag result diabet ef13 treat cancer ef27 reduc side effect radiotherapi clinic trial go well launch 1996 1997 scotia unusu pharmaceut compani concentr field essenti fatti acid deriv natur product virtual ignor rest industri instead centralis r amp manufactur facil small unit scatter around uk surrey outer hebrid basic research centr nova scotia canada